1. Home
  2. TPC vs ZYME Comparison

TPC vs ZYME Comparison

Compare TPC & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPC
  • ZYME
  • Stock Information
  • Founded
  • TPC 1894
  • ZYME 2003
  • Country
  • TPC United States
  • ZYME United States
  • Employees
  • TPC N/A
  • ZYME N/A
  • Industry
  • TPC General Bldg Contractors - Nonresidential Bldgs
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • TPC Consumer Discretionary
  • ZYME Health Care
  • Exchange
  • TPC Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • TPC 1.0B
  • ZYME 846.1M
  • IPO Year
  • TPC N/A
  • ZYME 2017
  • Fundamental
  • Price
  • TPC $37.85
  • ZYME $11.64
  • Analyst Decision
  • TPC Strong Buy
  • ZYME Buy
  • Analyst Count
  • TPC 2
  • ZYME 7
  • Target Price
  • TPC $40.50
  • ZYME $19.50
  • AVG Volume (30 Days)
  • TPC 742.7K
  • ZYME 449.0K
  • Earning Date
  • TPC 05-07-2025
  • ZYME 05-08-2025
  • Dividend Yield
  • TPC N/A
  • ZYME N/A
  • EPS Growth
  • TPC N/A
  • ZYME N/A
  • EPS
  • TPC N/A
  • ZYME N/A
  • Revenue
  • TPC $4,524,568,000.00
  • ZYME $93,384,000.00
  • Revenue This Year
  • TPC $19.51
  • ZYME $34.23
  • Revenue Next Year
  • TPC $14.66
  • ZYME $68.78
  • P/E Ratio
  • TPC N/A
  • ZYME N/A
  • Revenue Growth
  • TPC 8.95
  • ZYME 85.05
  • 52 Week Low
  • TPC $14.50
  • ZYME $8.21
  • 52 Week High
  • TPC $37.79
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • TPC 77.05
  • ZYME 48.92
  • Support Level
  • TPC $36.22
  • ZYME $11.02
  • Resistance Level
  • TPC $37.77
  • ZYME $11.81
  • Average True Range (ATR)
  • TPC 1.18
  • ZYME 0.57
  • MACD
  • TPC -0.05
  • ZYME -0.02
  • Stochastic Oscillator
  • TPC 100.00
  • ZYME 39.23

About TPC Tutor Perini Corporation

Tutor Perini Corp offers general contracting, construction management, and design-build services to private and public customers. The company constructs and repairs transportation infrastructure, water-treatment facilities, and a wide range of buildings. Tutor Perini has three operating segments: Civil, Building, and Specialty Contractors. A majority of its revenue is generated from the Civil segment, which specializes in public works construction and the replacement and reconstruction of infrastructure. Its civil contracting services include construction and rehabilitation of highways, bridges, tunnels, mass-transit systems, military and other government facilities, and water management and wastewater treatment facilities. Geographically, it derives key revenue from the United States.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: